Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co Ltd Offers Custom MCT for Pharmaceutical Excipients

Chinese Manufacturer Delivers GMP-Compliant, Supply Chain-Secure Contract Solutions

Guangzhou, China – 2026 – Global leading provider of high-end pharmaceutical excipients and active pharmaceutical ingredients (APIs), Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., today announced the expansion of its contract manufacturing services to include custom medium chain triglyceride (MCT) products for pharmaceutical excipients. This service addresses the critical supply chain gap for reliable, domestically produced MCT excipients, offering GMP-compliant production, international certification, and flexible customization options tailored to client needs. The custom MCT manufacturing service is now available globally, with production lead times adjusted to meet project timelines .

Core Technical Advantages & Product Highlights

Domestic Supply Chain Security

In 2023, the company’s medium chain triglyceride API received regulatory approval, breaking long-term foreign monopoly in the high-end pharmaceutical lipid sector. Guangzhou Baiyunshan Hanfang uses an integrated green extraction technology combining supercritical CO₂ extraction, membrane separation, and chromatography, replacing traditional polluting processes to ensure consistent quality and reduce environmental impact .

Flexible Customization

The contract manufacturing service supports tailored MCT specifications, including purity levels, packaging formats, and batch sizes, to meet the unique requirements of pharmaceutical, nutraceutical, and special medical food manufacturers. This flexibility allows clients to align production with their specific formulation and scaling needs .

Global Compliance & Certifications

All custom MCT products comply with international regulatory standards, including EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications. This ensures seamless market access across over 30 countries and regions where the company operates, supporting clients in meeting local compliance requirements .

Supply & Order Information

The custom MCT manufacturing service is now open for global orders through the company’s official website and authorized distributors. Production can be scaled from small R&D batches to large commercial volumes, with flexible delivery timelines designed to support both early-stage development and full-scale production .

Executive Quote

"The expansion of our custom MCT contract manufacturing service marks a significant step in our global strategy to address supply chain vulnerabilities for pharmaceutical excipients," said Xu Wendong, General Manager and Deputy Director of the National Engineering Research Center at Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. "We are committed to providing reliable, cost-effective solutions that meet the highest international quality standards for our global clients, supporting their efforts to secure stable supply chains ."

Industry Context & Strategic Alignment

According to industry analysis, the global pharmaceutical excipients market is growing due to increasing demand for secure, domestically sourced ingredients to mitigate supply chain risks. Guangzhou Baiyunshan Hanfang’s custom MCT service aligns with this trend, offering a trusted alternative to imported excipients while leveraging its national-level R&D capabilities to drive innovation in the sector .

Future Plans

Looking ahead, Guangzhou Baiyunshan Hanfang will continue to invest in R&D for high-end pharmaceutical lipids, expanding its contract manufacturing portfolio to include more specialized excipients. The company also plans to strengthen its global distribution network to provide localized support for clients in key markets, enhancing its ability to meet evolving global healthcare needs .

About Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.

Founded in 1998, Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. is a state-owned enterprise under the Guangzhou Pharmaceutical Holdings (GPH) Group. It is a national-level specialized, sophisticated, unique, and new "Little Giant" enterprise, with a focus on high-end pharmaceutical lipid excipients, APIs, and health products. The company operates the only national-level engineering research center for traditional Chinese medicine process technology, holds over 240 patents, and serves more than 1,000 clients across 30+ countries. Its mission is to advance self-reliance in biomedical technology and safeguard global healthcare supply chains. For more information, visit http://byshanhanfang.com/ .

Contact Information

Company: Guangzhou Hanfang Pharmaceutical Company Limited
Official Website: http://byshanhanfang.com/

© 2026 Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd. All rights reserved.